LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression
Mariano Provencio,
Patrick M. Forde,
J.D. Spicer,
C. Wang,
Shun Lu,
Tetsuya Mitsudomi,
Mark M. Awad,
Enriqueta Felip,
Stephen Broderick,
Steven Swanson,
Annals of Oncology · 2023 · 18 citations · 1 references